摘要
代谢综合征系多种代谢紊乱组分在体内"聚集"的一种病理状态,已成为全球公共健康主要问题。加强代谢综合征发生发展病理机制及药物干预等研究凸显重要。中药因其在防治代谢综合征方面具有一定的优势和特色而受到国内外学者持续关注与研究。本文主要综述中药干预代谢综合征的基础研究概况。
Metabolic syndrome, a cluster status of multiple metabolic disorders, has been one of the most common public health problems in the world. It was critical to investigate the pathological mechanism of metabolic syndrome by underlying the intervention of its medications. TCM showed unique characteristics and vantages in the prevention and treatment of metabolic syndrome of which field focused on both domestic and foreign scholars afterward. In this review, the basic research progress on TCM in the intervention of metabolic syndrome was summarized.
引文
1 Doyle S L,Donohoe C L,Lysaght J,et al.Visceral obesity,metabolic syndrome,insulin resistance and cancer.Proc Nutr Soc,2012,71(1):181-189.
2 Schwarz P E,Reimann M,Li J,et al.The Metabolic Syndrome-a global challenge for prevention.Horm Metab Res,2007,39(11):777-780.
3 Singh R B,Gupta S,Dherange P,et al.Metabolic syndrome:A brain disease.Can J Physiol Pharmacol,2012,90(9):1171-1183.
4 Brunzell J D.Clinical practice.Hypertriglyceridemia.N Engl J Med,2007,357(10):1009-1017.
5 Kahn R.Metabolic syndrome-What is the clinical usefulness?Lancet,2008,371(9628):1892-1893.
6 Hansen B C,Bray G A.The metabolic syndrome:Epidemiology clinical treatment and underlying mechanisms.Humana Press,2008.
7 甘亚丽,陈光亮.中药防治代谢综合征的实验研究进展.安徽医药,2010,14(1):10-12.
8 钟周,李晓屏,胡志希,等.中药治疗代谢综合征的疗效及药物安全性.中国老年学杂志,2015,35(19):5517-5518.
9 符佳,陈雪宇,张正琴,等.中药治疗代谢综合征的文献研究.世界中医药,2015,10(8):1257-1260.
10 Hu J Q,Peng J.TCM theoretical study on the etiology and pathogenesis of metabolic syndrome.J Tradit Chin Med,2006,26(3):239-240.
11 Lee T C,Lo L C,Wu F C.Traditional Chinese medicine for metabolic syndrome via TCM pattern differentiation:Tongue diagnosis for predictor.Evid Based Complement Alternat Med,2016,2016:1971295.
12 张倩,梁晓春.中医论治代谢综合征的研究进展.环球中医药,2011,4(2):157-160.
13 Miller A,Adeli K.Dietary fructose and the metabolic syndrome.Curr Opin Gastroenterol,2008,24(2):204-209.
14 Rutledge A C,Adeli K.Fructose and the metabolic syndrome:pathophysiology and molecular mechanisms.Nutr Rev,2007,65(6):S13-S23.
15 Lim J S,Mietus-Snyder M,Valente A,et al.The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.Nat Rev Gastroenterol Hepatol,2010,7(5):251-264.
16 Sampey B P,Vanhoose A M,Winfield H M,et al.Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation:Comparison to high-fat diet.Obesity,2011,19(6):1109-1117.
17 胡旭光,郭姣,贝伟剑,等.复方贞术调脂胶囊对MS大鼠胰岛素抵抗及胰岛素信号PI-3K的影响.中药新药与临床药理,2012,23(2):140-143.
18 王槾.复方贞术调脂方对胰岛素抵抗的作用及机制研究.广州:广东药学院硕士学位论文,2014.
19 肖雅.逍遥丸对高脂饮食诱导大鼠空腹血糖受损的影响及其机制研究.广州:南方医科大学硕士学位论文,2012.
20 王春怡.黄芪散干预2型糖尿病胰岛素抵抗机制及制剂基础研究.广州:广州中医药大学博士学位论文,2009.
21 Li J M,Li Y C,Kong L D,et al.Curcumin inhibits hepatic proteintyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats.Hepatology,2010,51(5):1555-1566.
22 Li J M,Wang W,Fan C Y,et al.Quercetin preserves beta-cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt/Fox O1 activation.Evid Based Complement Alternat Med,2013,2013:303902.
23夏2),关昊.复方中药对代谢综合征SD大鼠的干预研究.中华中医药杂志,2012,27(10):2668-2671.
24 殷锦锦.护肝清脂片对肝脂肪变性L02细胞模型的药理作用及机制研究.广州:南方医科大学硕士学位论文,2014.
25 Tan Y,Kamal M A,Wang Z Z,et al.Chinese herbal extracts(SK0506)as a potential candidate for the therapy of the metabolic syndrome.Clin Sci(Lond),2011,120(7):297-305.
26 Yin J,Zhang H,Ye J.Traditional chinese medicine in treatment of metabolic syndrome.Endocr Metab Immune Disord Drug Targets,2008,8(2):99-111.
27 王丹,石岩.中药复方“益糖康”对“脾虚证”代谢综合征大鼠血清炎症因子影响的实验研究.免疫学杂志,2013,29(6):549-552.
28 王清媛.三味药食同源中药对代谢综合征大鼠糖脂代谢及抗氧化的影响.大连:大连医科大学硕士学位论文,2011.
29 Hu Q H,Wang C,Li J M,et al.Allopurinol,rutin,and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake:Renal organic ion transporter involvement.Am J Physiol Renal Physiol,2009,297(4):F1080-1091.
30 Hu Q H,Zhang X,Pan Y,et al.Allopurinol,quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats.Biochem Pharmacol,2012,84(1):113-125.
31 Zhang X,Zhang J H,Chen X Y,et al.Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.Antioxid Redox Signal,2015,22(10):848-870.
32 Ge C X,Yu R,Xu M X,et al.Betaine prevented fructose-induced NAFLD by regulating LXRalpha/PPARalpha pathway and alleviating ER stress in rats.Eur J Pharmacol,2016,770:154-164.
33 Ding X Q,Gu T T,Wang W,et al.Curcumin protects against fructoseinduced podocyte insulin signaling impairment through upregulation of mi R-206.Mol Nutr Food Res,2015,59(12):2355-2370.
34 Wang W,Ding X Q,Gu T T,et al.Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via micro RNA-377.Free Radic Biol Med,2015,83:214-226.
35 杨宇峰.中药复方益糖康干预代谢综合征的疗效评价及其代谢组学研究.沈阳:辽宁中医药大学博士学位论文,2012.
36 Demir S,Artim-Esen B,Sahinkaya Y,et al.Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage:a cross-sectional analysis of 311 patients.Lupus,2016,25(2):177-184.
37 Ma C H,Kang L L,Ren H M,et al.Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NFkappa B/NLRP3 inflammasome activation in high fructose-fed rats.J Ethnopharmacol,2015,172:108-117.
38 Yang Y,Zhang D M,Liu J H,et al.Wuling San protects kidney dysfunction by inhibiting renal TLR4/My D88 signaling and NLRP3inflammasome activation in high fructose-induced hyperuricemic mice.J Ethnopharmacol,2015,169:49-59.
39 Zhang D M,Li Y C,Xu D,et al.Protection of curcumin against fructose-induced hyperuricaemia and renal endothelial dysfunction involves NO-mediated JAK-STAT signalling in rats.Food Chem,2012,134(4):2184-2193.
40 Wang X,Zhang D M,Gu T T,et al.Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway.Biochem Pharmacol,2013,86(12):1791-1804.
41 杨扬,王军,程晓霞,等.复方黄芪首乌合剂对MS大鼠AngⅡ、FFA分泌及氧化应激反应的作用.中国中西医结合肾病杂志,2015,16(1):6-8.
42 王军.复方黄芪首乌合剂对代谢综合征(MS)大鼠早期肾损伤的保护作用及分子机制研究.杭州:浙江中医药大学博士学位论文,2013.
43 王军,程晓霞,涂晓,等.复方黄芪首乌汤对MS大鼠足细胞损伤的保护作用的实验研究.浙江省中医药学会肾病分会学术年会暨国家级中医药继续教育项目“慢性肾脏病临床实践与新进展”学习班暨慢性肾脏病中医临床路径学术研讨会,2011.
44 王军,程晓霞,朱晓玲,等.复方黄芪首乌合剂对代谢综合征大鼠肾组织Nephrin和Podocin的调节作用.中华中医药学刊,2014,32(3):606-610.
45 孙兴华,张立强,贺蓓,等.复方丹参滴丸对代谢综合征模型大鼠胸骨舌骨肌结构和功能的影响.中国中西医结合杂志,2011,31(12):1680-1684.
46 Zurlo A,Veronese N,Giantin V,et al.High serum uric acid levels increase the risk of metabolic syndrome in elderly women:The PRO.V.A study.Nutr Metab Cardiovasc Dis,2016,26(1):27-35.
47 Yuan H,Yu C,Li X,et al.Serum Uric Acid Levels and Risk of Metabolic Syndrome:A Dose-Response Meta-Analysis of Prospective Studies.J Clin Endocrinol Metab,2015,100(11):4198-4207.
48 Gurusamy N,Vijayaraghavalu S,Alhazzani A,et al.The enigma of uric acid in metabolic syndrome.Diabesity,2015,1(3):2.
49 De Bosch B J,Kluth O,Fujiwara H,et al.Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9.Nat Commun,2014,5:4642.
50 Yoo T W,Sung K C,Shin H S,et al.Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.Circ J,2005,69(8):928-933.
51 Hayden M R,Tyagi S C.Uric acid:A new look at an old risk marker for cardiovascular disease,metabolic syndrome,and type 2 diabetes mellitus:The urate redox shuttle.Nutr Metab(Lond),2004,1(1):10.
52 Abate N,Chandalia M,Cabo-Chan A V,et al.The metabolic syndrome and uric acid nephrolithiasis:novel features of renal manifestation of insulin resistance.Kidney Int,2004,65(2):386-392.
53 Pan Y,Hong Y,Zhang Q Y,et al.Impaired hypothalamic insulin signaling in CUMS rats:restored by icariin and fluoxetine through inhibiting CRF system.Psychoneuroendocrino,2013,38(1):122-134.
54 Knol M J,Twisk J W,Beekman A T,et al.Depression as a risk factor for the onset of type 2 diabetes mellitus.A meta-analysis.Diabetologia,2006,49(5):837-845.
55 Mezuk B,Eaton W W,Albrecht S,et al.Depression and type 2 diabetes over the lifespan:a meta-analysis.Diabetes Care,2008,31(12):2383-2390.
56 Li J M,Ge C X,Xu M X,et al.Betaine recovers hypothalamic neural injury by inhibiting astrogliosis and inflammation in fructose-fed rats.Mol Nutr Food Res,2015,59(2):189-202.
57 Zhang Q Y,Pan Y,Wang R,et al.Quercetin inhibits AMPK/TXNIP activation and reduces inflammatory lesions to improve insulin signaling defect in the hypothalamus of high fructose-fed rats.J Nutr Biochem,2014,25(4):420-428.
58 Xu M X,Yu R,Shao L F,et al.Up-regulated fractalkine(FKN)and its receptor CX3CR1 are involved in fructose-induced neuroinflammation:Suppression by curcumin.Brain Behav Immun,2016.
